Skip to main content
SpringerLink
Log in

Ursolic acid and rosiglitazone combination improves insulin sensitivity by increasing the skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat diet-fed C57BL/6J mice

  • Original Paper
  • Published:
Journal of Physiology and Biochemistry Aims and scope Submit manuscript

Abstract

The aim of this present study was to investigate the effect of ursolic acid (UA) and rosiglitazone (RSG) on insulin sensitivity and proximal insulin signaling pathways in high-fat diet (HFD)-fed C57/BL/6J mice. Male C57BL/6J mice were fed either normal diet or HFD for 10 weeks, after which animals in each dietary group were divided into the following six groups (normal diet, normal diet plus UA and RSG, HFD alone, HFD plus UA, HFD plus RSG, and HFD plus UA and RSG) for the next 5 weeks. UA (5 mg/kg BW) and RSG (4 mg/kg BW) were administered as suspensions directly into the stomach using a gastric tube. The HFD diet elevated fasting plasma glucose, insulin, and homeostasis model assessment index. The expression of insulin receptor substrate (IRS)-1, phosphoinositide 3-kinase (PI3-kinase), Akt, and glucose transporter (GLUT) 4 were determined by Western blot analyses. The results demonstrated that combination treatment (UA/RSG) ameliorated HFD-induced glucose intolerance and insulin resistance by improving the homeostatic model assessment (HOMA) index. Further, combination treatment (UA/RSG) stimulated the IRS-1, PI3-kinase, Akt, and GLUT 4 translocation. These results strongly suggest that combination treatment (UA/RSG) activates IRS-PI3-kinase-Akt-dependent signaling pathways to induce GLUT 4 translocation and increases the expression of insulin receptor to improve glucose intolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Abdin AA, Baalash AA, Hamooda HE (2010) Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers. J Diabetes Complicat 24(3):168–178

    Article  PubMed  Google Scholar 

  2. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher, Bonadonna R, Muggeo M (2002) HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Diabetes Care 25(7):1135–1141

    Article  PubMed  Google Scholar 

  3. Burgi W, Briner M, Franken N, Kessler AC (1998) One step sandwich enzyme immunoassay for insulin using monoclonal antibodies. Clin Biochem 21(5):311–314

    Article  Google Scholar 

  4. Carvalho E, Rondinone C, Smith U (2000) Insulin resistance in fat cells from obese Zucker rats—evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol Cell Biochem 206(1-2):7–16

    Article  CAS  PubMed  Google Scholar 

  5. Chakraborty C (2006) Biochemical and molecular basis of insulin resistance. Curr Protein Pept Sci 7(2):113–121

    Article  CAS  PubMed  Google Scholar 

  6. Chang L, Chiang SH, Saltiel AR (2004) Insulin signaling and the regulation of glucose transport. Mol Med 10(7-12):65–71

    CAS  PubMed  PubMed Central  Google Scholar 

  7. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14(3):173–194

    Article  CAS  PubMed  Google Scholar 

  8. DeFronzo RA, Ferrannini E, Simonson DC (1989) Fasting hyperglycemia in noninsulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38(4):387–395

    Article  CAS  PubMed  Google Scholar 

  9. Fujitani Y, Ueno T, Watada H (2010) The role of pancreatic beta-cell autophagy in health and diabetes. Am J Physiol Cell Physiol 299(1):C1–C6

    Article  CAS  PubMed  Google Scholar 

  10. Grundy SM (2006) Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 5(4):295–309

    Article  CAS  PubMed  Google Scholar 

  11. Grundy SM (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92(2):399–404

    Article  CAS  PubMed  Google Scholar 

  12. Huang S, Czech MP (2007) The GLUT4 glucose transporter. Cell Metab 5(4):237–252

    Article  CAS  PubMed  Google Scholar 

  13. Jayaprakasam B, Olson LK, Schutzki RE, Tai MH, Nair MG (2005) Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in cornelian cherry (cornus mas). J Agric Food Chem 54(1):243–248

    Article  Google Scholar 

  14. Johnson AM, Olefsky JM (2013) The origins and drivers of insulin resistance. Cell 152(4):673–684

    Article  CAS  PubMed  Google Scholar 

  15. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405(6785):421–424

    Article  CAS  PubMed  Google Scholar 

  16. Kim JK, Michael MD, Previs SF, Peroni OD, Mauvais-Jarvis F, Neschen S, Kahn BB, Kahn CR, Shulman GI (2000) Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest 105(12):1791–1797

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kruszynska YT, Olefsky JM (1996) Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J Investig Med 44(8):413–428

    CAS  PubMed  Google Scholar 

  18. Larsen MO, Juhl CB, Pørksen N, Gotfredsen CF, Carr RD, Ribel U, Wilken M, Rolin B (2005) Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs. Am J Physiol Endocrinol Metab 288(2):E412–E421

    Article  CAS  PubMed  Google Scholar 

  19. Lee YS, Cha BY, Saito K, Yamakawa H, Choi SS, Yamaguchi K, Yonezawa T, Teruya T, Nagai K, Woo JT (2010) Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Biochem Pharmacol 79(11):1674–1683

    Article  CAS  PubMed  Google Scholar 

  20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275

    CAS  PubMed  Google Scholar 

  21. Lu J, Zheng YL, Wu DM, Luo L, Sun DX, Shan Q (2007) Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Biochem Pharmacol 74(7):1078–1090

    Article  CAS  PubMed  Google Scholar 

  22. Maier VH, Gould GW (2000) Long term insulin treatment of 3T3-L1 adipocytes results in mis-targeting of GLUT4: implications for insulin-stimulated glucose transport. Diabetologia 43(10):1273–1281

    Article  CAS  PubMed  Google Scholar 

  23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419

    Article  CAS  PubMed  Google Scholar 

  24. Miyazaki Y, He H, Mandarino LJ, DeFronzo RA (2003) Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients. Diabetes 52(8):1943–1950

    Article  CAS  PubMed  Google Scholar 

  25. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R (2003) Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation 108(23):2941–2948

    Article  PubMed  Google Scholar 

  26. Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18(3):363–374

    Article  CAS  PubMed  Google Scholar 

  27. Otto C, Lehrke M, Goke B (2002) Novel insulin sensitizers: pharmacogenomic aspects. Pharmacogenomics 3(1):99–116

    Article  CAS  PubMed  Google Scholar 

  28. Pessin JE, Saltiel AR (2000) Signalling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106(2):165–169

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Phillips LS, Grunberger G, Miller E, Patwardhan R, Rappaport EB, Salzman A (2001) Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes. Diabetes Care 24(2):308–315

    Article  CAS  PubMed  Google Scholar 

  30. Pittas AG, Joseph NA, Greenberg AS (2004) Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89(2):447–452

    Article  CAS  PubMed  Google Scholar 

  31. Radhiga T, Rajamanickam C, Sundaresan A, Ezhumalai M, Pugalendi KV (2012) Effect of ursolic acid treatment on apoptosis and DNA damage in isoproterenol-induced myocardial infarction. Biochimie 94(5):1135–1142

    Article  CAS  PubMed  Google Scholar 

  32. Ruderman NB, Cacicedo JM, Itani S, Yagihashi N, Saha AK, Ye JM, Chen K, Zou M, Carling D, Boden G, Cohen RA, Keaney J, Kraegen EW, Ido Y (2003) Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. Biochem Soc Trans 31(1):202–206

    Article  CAS  PubMed  Google Scholar 

  33. Saltiel AR, Pessin JE (2002) Insulin signaling pathways in time and space. Trends Cell Biol 12(2):65–71

    Article  CAS  PubMed  Google Scholar 

  34. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Moonen-Kornips E, Schaart G, Mustard KJ, Hardie DG, Saris WH, Nicolay K, Schrauwen P (2005) Intramyocellular lipid content and molecular adaptations in response to a 1-week high-fat diet. Obes Res 13(12):2088–2094

    Article  CAS  PubMed  Google Scholar 

  35. Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106(2):171–176

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37(9):1163–1167

    Article  CAS  PubMed  Google Scholar 

  37. Vasudevan AR, Balasubramanyam A (2004) Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability. Diabetes Technol Ther 6(6):850–863

    Article  CAS  PubMed  Google Scholar 

  38. Virkamäki A, Ueki K, Kahn CR (1999) Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103(7):931–943

    Article  PubMed  PubMed Central  Google Scholar 

  39. Weir GC, Bonner-Weir S (2007) A dominant role of glucose in β-cell compensation of insulin resistance. J Clin Invest 117(1):81–83

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A (2001) β-cell adaptation and decomposition during the progression of diabetes. Diabetes 50(1):S154–S159

    Article  CAS  PubMed  Google Scholar 

  41. White MF (2003) Insulin signaling in health and disease. Science 302(5651):1710–1711

    Article  CAS  PubMed  Google Scholar 

  42. Zhang F, Ye C, Li G, Ding W, Zhou W, Zhu H, Chen G, Luo T, Guang M, Liu Y, Zhang D, Zheng S, Yang J, Gu Y, Xie X, Luo M (2003) The rat model of type 2 diabetic mellitus and its glycol metabolism characters. Exp Anim 52(5):401–407

    Article  CAS  PubMed  Google Scholar 

  43. Zhang W, Hong D, Zhou Y, Zhang Y, Shen Q, Li JY, Hu LH, Li J (2006) Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochim Biophys Acta 1760(10):1505–1512

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The financial support to Arjunan Sundaresan as Senior Research Fellowship (No. 3/1/2/22/2010-RHNdated16.08.2010) from Indian Council of Medical Research (ICMR), New Delhi, is gratefully acknowledged.

Author information

Authors and Affiliations

  1. Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, 608 002, Tamil Nadu, India

    Arjunan Sundaresan, Thangaiyan Radhiga & Kodukkur Viswanathan Pugalendi

Authors
  1. Arjunan Sundaresan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thangaiyan Radhiga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kodukkur Viswanathan Pugalendi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kodukkur Viswanathan Pugalendi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sundaresan, A., Radhiga, T. & Pugalendi, K.V. Ursolic acid and rosiglitazone combination improves insulin sensitivity by increasing the skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat diet-fed C57BL/6J mice. J Physiol Biochem 72, 345–352 (2016). https://doi.org/10.1007/s13105-016-0484-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13105-016-0484-6

Keywords

Search

Navigation